Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A specialized interprofessional clinical program at Princess Margaret Cancer Centre is helping cancer patients on immunotherapy avoid side effects that could impact their treatment plan or lead to urgent hospital visits.
The Immune and Molecular Therapy Bolstering and Supporting Patient Adverse Events (IMBRASE) Program facilitates proactive symptom assessment and management for melanoma patients receiving immunotherapy treatment.
Immunotherapy is a rapidly advancing field in cancer treatment and teams have to adjust rapidly alongside it.
Compared to chemotherapy, immunotherapy is more idiosyncratic – with side effects occurring differently for different people and sometimes starting out very subtly.
This makes it challenging for patients to know when they should tell their care team about their symptoms, and for staff in knowing what they should look out for and when.
"Patients are hesitant to tell us about initial symptoms that may seem minor, like little rashes or loose bowel movements," says Dr. Marcus Butler, medical oncologist and Clinical Head of the Immune Profiling Team at the Princess Margaret. "These side effects seem insignificant at first, but minor things left unmonitored could lead to bigger problems."
Addressing the gap in care
If left unchecked, these minor symptoms could mean urgent clinic or Emergency Department (ED) visits, and could even interfere with treatment plans.
A need emerged to address the gap in care to support patients and nurses in helping identifying symptoms or side effects early, before they cause trouble.
Nancy Gregorio, Registered Nurse in Princess Margaret's Melanoma Clinic, stepped up through UHN's CAP (collaborative academic practice) Fellowship Program to develop IMBRASE: a remote, cost-effective and proactive approach to ensure patient safety and support during treatment, while bolstering confidence and education for nurses.
Buy-in from the team was widespread.
"Everyone was incredibly motivated to prevent any challenging situations for our patients," says Nancy. "There was a consensus that a gap existed in this part of the patient journey and everyone wanted to bridge the gap."
The project started with a process mapping exercise and after more than six months of teamwork evolved into a robust remote assessment tool that allows the team to:
After IMBRASE was implemented, more than 80 per cent of patients received proactive phone calls to check in about their symptoms, and the rate of ED visits for high-risk patients reduced significantly.
"Our patients feel more supported and we have the opportunity to identify problems before they occur," says Dr. Butler. "We're also able to have a better understanding of how quickly a side effect develops, which expands our knowledge and helps us respond appropriately."
The program was so successful it was awarded the
2020 Quality Award from the Cancer Quality Council of Ontario (Ontario Health), making this the third consecutive year the Princess Margaret has been one of two awarded across the province for either quality or innovation.
"It's an honour to be recognized amongst our colleagues across the province," says Michelle Mackay, Nurse Manager, Solid Tumor Oncology Ambulatory and Urgent Care at the cancer centre.
"What's particularly exciting is that this is a cost-effective program that could be applied to different cancer centres and disease sites. It could benefit many, not just a few."
Throughout implementation, the incredible teamwork from the melanoma team stands out for Nancy.
"We worked well as a team even before this," she says. "But now, with COVID and increasing virtual care, we work even better. We support each other, step in when needed, and we've rallied around our goal to close this gap.
"We should be proud of how far we've come."